Mithra Announces New Polymer Technology Development for a Leading Veterinarian Company

  • First veterinary R&D project concluded with one of the world’s largest animal health players, CEVA
  • Development of an innovative hormonal device for the bovine fertility market
  • Expansion of Mithra CDMO polymer technology expertise attracts new development partners

Liege, Belgium, 20 February 2019 – 7:30  CET – Mithra (Euronext Brussels: MITRA), a company dedicated to Women’s Health announces today that it has signed a contract with the CEVA Animal Health group to develop a hormonal device for the veterinary market. CEVA Animal Health is one of the ten largest veterinary pharmaceutical groups in the world and develops products that meet the specific needs of the various sectors of this market, particularly bovines.